Larimar Therapeutics, Inc.·4

May 12, 8:27 PM ET

Barrett Peter 4

4 · Larimar Therapeutics, Inc. · Filed May 12, 2022

Insider Transaction Report

Form 4
Period: 2022-05-10
Barrett Peter
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-10+8,3008,300 total
    Exercise: $2.92Exp: 2032-05-10Common Stock (8,300 underlying)
Footnotes (1)
  • [F1]The options vest on the earlier of (a) May 10, 2023 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES